Abd Al-Roof Higazi

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

Aqueduct Medical Ltd. develops a technology for use in dilating the uterine cervix and various other body cavities. The company was founded by Omer Harpaz and is headquartered in Nazareth Elit, Israel.

Eio Biomedical Ltd. operates as a biotechnology company developing a medical device for the prevention of post-surgical adhesions. The company was founded in 2006 and is headquartered in Nazareth, Israel.

Nurami Medical Ltd. develops surgical scaffold platform for the repair, regeneration and healing of soft tissues following internal surgeries. Its product pipeline include Artifascia and Artifix. The company was founded by Amir Bahar and Nora Nseir in 2014 and is headquartered in Haifa, Israel.

Paragate Medical Ltd. engages in the development of implantable device for the treatment of fluid overload in patients suffering from chronic heart or kidney failure. The company was founded by Nitai Hanani and Yair Feld in 2016 and is headquartered in Haifa, Israel.

Virility Medical Ltd. engages in developing intimate skin patch for the treatment of premature ejaculation. The company was founded by Tal Gollan and is headquartered in Nazareth Elit, Israel.

Implant B Ltd. engages in the development of a multi piece dental implant for treating peri-implantitis while preserving the implant and the dental restoration. The company was founded by Liat Chaushu on July 21, 2014 and is headquartered in Nazareth, Israel.

Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel.

OTTek Ltd. is an Israeli medical device company that specializes in state-of-the-art innovative practical GI endoscopy solutions. The company is based in Nazareth, Israel. The company has developed the FIoT (Flow in Over Tube), a versatile, on-demand, easy-to-assemble, cost-effective colonoscopy assist device. The company was founded in 2018, and the CEOs are Yoav Lichtenstein and Zohar Gendler.

Intragel Therapeutics Ltd. is an Israeli science-based company that develops an innovative, state-of-the-art treatment for solid tumors based on an intra-tumoral injectable delivery system with extended release of anticancer drugs. The company is based in Nazareth, Israel. The company's technology can be applied to a wide range of anti-cancer drugs and is suitable for various types of solid tumors. Intragel's formula is loaded into a ready-to-use pre-filled syringe, which is applied directly into the tumors. The drug is slowly released, shrinking the tumor without side effects. Intragel was founded by Peter Siman, Avi Domb, and Avner Geva, and Peter Siman has been the CEO since incorporation.

Nina Medical Ltd. specializes in ultrasound imaging of the prostate and pelvic floor, as well as non-invasive, focal therapy of the prostate using high-intensity focused-ultrasound (HIFU). The company is based in Nazareth, Israel. The Israeli company is a pioneer in ultrasound imaging of HIFU, where the therapeutic field is captured and displayed by the diagnostic field. Nina Medical introduces the concept of the therapeutic pillow, a membrane-covered integrated applicator for diagnostic and therapeutic ultrasound, which delivers HIFU energy to the prostate while providing treatment planning, guidance, and control. Shmuel Ben-Ezra has been the CEO of the company since 2019.

Ark Surgical Ltd. is an Israeli medical device company that specializes in the commercialization of the LapBox tissue containment removal system. The company is based in Israel and was founded by Abraham Yaari, Aaron Feldman. The LapBox is a safe and minimally-invasive alternative for gynecologists using laparoscopic surgery. The company was founded by medical device veterans with hands-on experience in the clinical setting and operates as a portfolio company of the NGT³ venture capital fund. The CEO is Stav Tori.

ParaSonic Ltd. engages in the development of a device for lice infestations. It offers CARELY a home-use device that kills lice and their eggs in a single combing treatment. The company was founded by Mor Cohen and is headquartered in Tel Aviv, Israel.

A.R Guide In Medical Ltd. operates as a medical device company engaging in the development of non-invasive guided intubation device. The company was founded by Ariel Shrem, Elchanan Fried, and Itai Hayut in 2015 and is headquartered in Nazareth, Israel.

Tendomend Ltd. is developing an invasive implant and a corresponding deployment system to replace the current suturing approach in tendon repair. The company was founded by Valavanis Ioannis and Almon Ehud on February 17, 2019 and is headquartered in Nazareth, Israel.

Plas-Free Ltd. develops revolutionizing massive bleeding treatment medical devices. The company was founded by Abd Al-Roof Hijazi and is headquartered in Nazareth, Israel.

Part of Purple Biotech Ltd., Kitov Pharmaceuticals Ltd. is committed to providing cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance. The Israeli company's proposed drug, CM24, attenuates/block tumor growth and metastatic processes, while their novel small molecule, NT219, targets both IRS1/2 and STAT3. CM24 is a monoclonal antibody blocking CEACAM1, and NT219 targets the novel cancer drug resistance pathways. Kitov Pharmaceuticals was acquired by Mainrom Line Logistics Ltd. on July 18, 2013.

NGT New Generation Technologies Ltd (NGT3) is a venture capital firm founded in 2002 by Nasri Said and Kayid Abu Ayash. The firm is headquartered in Nazareth Eli, Israel.

Technion Seed Ltd. (Technion Seed) is an independent Israeli seed-stage investment firm which was established in 1991 as the Technion Incubator. The firm is headquartered in Haifa, Israel.

Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel

CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel.

Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel.

Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Beta-O2 Technologies Ltd. develops implantable bio-artificial pancreas devices. It offers BAir, a bio-artificial pancreas that provides a viable environment for islets of Langerhans to thrive and provide the body with insulin on demand. The company was founded by Pnina Vardi, Konstantin Bloch, and Yossi Gross in 2004 and is headquartered in Rosh-Haayin, Israel.

Nervomatrix Ltd. develops non-invasive drug-free pain relief products for the pain clinicians' market. It offers Auto-Targeting Neurostimulation, a back-pain relief solution that allows pain clinicians to treat only the specific area identified to be effective for pain relief. The company was founded by Miguel Gorenberg in 2007 and is headquartered in Kfar Haroeh, Israel.